This approach achieves 92.28% accuracy for breast cancer classification in multiple datasets, suggesting potential clinical benefits.
Breast cancer remains one of the most prevalent cancers among women and a major cause of cancer-related mortality worldwide. Early and accurate detection is essential for reducing mortality rates, and mammography remains the most effective screening tool. This study proposes a convolutional neural network (CNN) framework for BI-RADS-based breast cancer classification using three publicly available datasets: CBIS-DDSM, INbreast, and KAU-BCMD. A comprehensive preprocessing pipeline, including noise reduction, contrast enhancement, and region-of-interest extraction, was applied, followed by data augmentation to improve generalization. The model was trained and optimized through grid search across multiple hyperparameter settings. The best configuration, with a learning rate of 0.001 and batch size of 32, achieved 92.28% test accuracy, with precision of 99.1% for BI-RADS4-5 cases and recall of 99.5% for BI-RADS 1 cases. These results demonstrate the potential of a custom CNN with robust preprocessing for BI-RADS based detection of breast cancer and highlight its clinical applicability for improving breast cancer detection.
No takes yet. Share an insight, caveat, or question.
Samad et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: